We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.6B
1-Year Est. Return 24.87%
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.42%
5 Year Est. Return
+80.33%
10 Year Est. Return
AUM
$7.93B
AUM Growth
+$314M
Cap. Flow
+$948M
Cap. Flow %
11.95%
Top 10 Hldgs %
31.01%
Holding
3,334
New
245
Increased
1,176
Reduced
923
Closed
594

Sector Composition

Rank Sector Weight
1 Technology 12.05%
2 Financials 6.74%
3 Industrials 4.89%
4 Healthcare 3.63%
5 Consumer Discretionary 3.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCI icon
1026
Crown Castle
CCI
$32.2B
$138K ﹤0.01%
1,555
-2,624
-63% -$241K
ALV icon
1027
Autoliv
ALV
$9B
$137K ﹤0.01%
1,150
-198
-15% -$23.6K
SOLS
1028
Solstice Advanced Materials
SOLS
$9.68B
$136K ﹤0.01%
+2,802
New +$132K
IFRA icon
1029
iShares US Infrastructure ETF
IFRA
$4.6B
$136K ﹤0.01%
2,579
+12
+0.5% +$634
TECX
1030
Tectonic Therapeutic
TECX
$606M
$136K ﹤0.01%
6,500
+5,000
+333% +$92.9K
SMTC icon
1031
Semtech
SMTC
$13B
$135K ﹤0.01%
1,833
+827
+82% +$58.7K
XLC icon
1032
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
$135K ﹤0.01%
1,146
FNDC icon
1033
Schwab Fundamental International Small Company Index ETF
FNDC
$3.16B
$134K ﹤0.01%
3,015
-5
-0.2% -$222
TRMB icon
1034
Trimble
TRMB
$13.9B
$134K ﹤0.01%
1,714
+1,103
+181% +$87.9K
IYK icon
1035
iShares US Consumer Staples ETF
IYK
$1.43B
$134K ﹤0.01%
2,000
+340
+20% +$23.1K
RYTM icon
1036
Rhythm Pharmaceuticals
RYTM
$7.96B
$133K ﹤0.01%
1,246
+847
+212% +$89.8K
VOYA icon
1037
Voya Financial
VOYA
$9.19B
$133K ﹤0.01%
1,787
+1,103
+161% +$80.4K
SRPT icon
1038
Sarepta Therapeutics
SRPT
$1.77B
$133K ﹤0.01%
6,185
-6,184
-50% -$130K
IR icon
1039
Ingersoll Rand
IR
$33.7B
$133K ﹤0.01%
1,674
+804
+92% +$63.5K
LNC icon
1040
Lincoln National
LNC
$8.81B
$131K ﹤0.01%
2,949
-169
-5% -$7.04K
FNDE icon
1041
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10B
$130K ﹤0.01%
3,607
-24
-0.7% -$876
LW icon
1042
Lamb Weston
LW
$7.19B
$130K ﹤0.01%
3,101
+229
+8% +$13.5K
LKQ icon
1043
LKQ Corp
LKQ
$6.29B
$129K ﹤0.01%
4,280
-288
-6% -$8.69K
IBB icon
1044
iShares Biotechnology ETF
IBB
$9.71B
$129K ﹤0.01%
764
-2
-0.3% -$325
BMI icon
1045
Badger Meter
BMI
$4.03B
$128K ﹤0.01%
736
+5
+0.7% +$900
CALX icon
1046
Calix
CALX
$2.39B
$128K ﹤0.01%
2,419
+1,981
+452% +$115K
NNBR icon
1047
NN Inc
NNBR
$311M
$128K ﹤0.01%
100,000
HIO
1048
Western Asset High Income Opportunity Fund
HIO
$340M
$128K ﹤0.01%
34,375
-17,324
-34% -$65.6K
SMH icon
1049
VanEck Semiconductor ETF
SMH
$71.8B
$127K ﹤0.01%
354
+162
+84% +$56.8K
HSIC icon
1050
Henry Schein
HSIC
$9.82B
$127K ﹤0.01%
1,681
+696
+71% +$49K

Similar funds

Clearstead Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Clearstead Advisors held 3,334 positions worth $7.93B, up 4.1% from $7.62B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Clearstead Advisors deployed $948M of net new capital in Q4 2025, opening 245 new positions and adding to 1,176 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 1,170,336 shares worth $734M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Invesco BulletShares 2027 Corporate Bond ETF, an estimated $29.8M trimmed.

  • Clearstead Advisors's largest Q4 2025 buy was Vanguard S&P 500 ETF: 1,170,336 shares worth $734M.
  • Clearstead Advisors added most to Invesco BulletShares 2033 Corporate Bond ETF in Q4 2025, an estimated $32.2M increase.
  • Clearstead Advisors's biggest Q4 2025 reduction was Invesco BulletShares 2027 Corporate Bond ETF, cutting an estimated $29.8M.
  • Clearstead Advisors fully exited Kellanova in Q4 2025, selling an estimated $2.05M.
  • Clearstead Advisors's ten largest holdings make up 31% of its $7.93B portfolio in Q4 2025.
  • Clearstead Advisors opened 245 new positions and closed 594 in Q4 2025.
  • Clearstead Advisors's portfolio value rose 4.1% quarter-over-quarter to $7.93B.

Based on Clearstead Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.